Search Results for keywords:"pharmaceutical supply chain"

Search Results: keywords:"pharmaceutical supply chain"

S. 527 — To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
February 11, 2025
Status:Introduced in Senate
Congress:119
Words:952
The bill, titled the "Prescription Pricing for the People Act of 2025," directs the Federal Trade Commission (FTC) to study intermediaries in the pharmaceutical supply chain, like pharmacy benefit managers. The FTC must look into the pricing practices and competitive behavior of these...
Simple Explanation
The bill wants the government to look closely at how companies that help with medicine prices are doing their job and find ways to make medicine cheaper and fairer for people to buy. It asks for a report to tell Congress how to make this better with some rules.
H. R. 6802 — To improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
💰
December 14, 2023
Status:Introduced in House
Congress:118
Words:2,324
The Rolling Active Pharmaceutical Ingredient and Drug Reserve Act, also known as the "RAPID Reserve Act" (H. R. 6802), aims to strengthen the supply chain of critical drugs and their active ingredients in the United States. It authorizes the Secretary of Health and Human...
Simple Explanation
The RAPID Reserve Act is like a plan to store extra medicine in case we run out during emergencies. It wants to make sure important medicines are made at home in the USA and saved up so people can always get them when needed.
H. R. 6992 — To require the Secretary of Health and Human Services to establish a list of essential medicines, and for other purposes.
January 12, 2024
Status:Introduced in House
Congress:118
Words:1,353
H.R. 6992, known as the “Mapping America’s Pharmaceutical Supply Act” or "MAPS Act," instructs the Secretary of Health and Human Services to create and regularly update a list of essential medicines critical to public health and safety. This list focuses on drugs necessary to...
Simple Explanation
The MAPS Act wants to make sure people have the important medicines they need by having a special list and checking where medicines come from so they don't run out during emergencies, while keeping some information secret to stay safe.
S. 527 — To require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
April 10, 2025
Status:Reported to Senate
Congress:119
Words:1,034
S. 527, known as the "Prescription Pricing for the People Act of 2025," requires the Federal Trade Commission (FTC) to conduct a study on intermediaries in the pharmaceutical supply chain. The FTC must report to Congress on various issues such as pharmacy benefit manager...
Simple Explanation
The Prescription Pricing for the People Act of 2025 asks a group called the FTC to look at people in between who help get medicine from the makers to the stores, to see if they are being fair with prices. This group then has to tell the government what they find and suggest ways to make it better by making sure everyone is playing fair.

Showing 1 to 4 of 4 results